About TIRECS Unit

For many years now, nuclear medicine has been a crucial tool both for the detection of cancers
using molecular imaging and for the treatment of tumors using targeted radionuclide therapy.

The anti-cancer center Centre Georges-François Leclerc (CGFL) of Dijon has technical expertise in preclinical and clinical imaging, as well as translational research capabilities through its Nuclear Medicine Department which hosts the CGFL’s lab for diagnostic IMAging and radioTHERanostics (IMATHERa). In this context, the IMATHERa team aims to become a reference center for the preclinical development of innovative theranostic strategies in oncology, pulmonary fibrosis, cardiovascular diseases and preclinical imaging methodology.

Thanks to its strategic location on the Dijon university campus and its membership of the GIE Pharm’image®, the IMATHERa team works with a number of highly specialized local partners in complementary fields, ranging from the design of molecules for radiotheranostics (ICMUB, CheMatech) to the processing of patient images (CGFL, CHU Dijon) and preclinical validation (Oncodesign, IMATHERa), providing a unique field of local expertise. Its proximity to eminent research centers (INSERM, UB, CNRS) and clinicians means that IMATHERa is part of a translational research approach dedicated to patients.